Copeptin and insulin resistance: effect modification by age and 11 β-HSD2 activity in a population-based study.

about

Copeptin and insulin resistance: effect modification by age and 11 β-HSD2 activity in a population-based study.

Item

http://www.wikidata.org/entity/Q47319650

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Copeptin and insulin resistanc ...... y in a population-based study.

@en

Copeptin and insulin resistanc ...... y in a population-based study.

@nl

type

Item

label

Copeptin and insulin resistanc ...... y in a population-based study.

@en

Copeptin and insulin resistanc ...... y in a population-based study.

@nl

prefLabel

Copeptin and insulin resistanc ...... y in a population-based study.

@en

Copeptin and insulin resistanc ...... y in a population-based study.

@nl

P1476

Copeptin and insulin resistanc ...... y in a population-based study.

@en

P2093

A Pechère-Bertschi

http://www.w3.org/2001/XMLSchema#string

B Ponte

http://www.w3.org/2001/XMLSchema#string

D Ackermann

http://www.w3.org/2001/XMLSchema#string

G Ehret

http://www.w3.org/2001/XMLSchema#string

I Guessous

http://www.w3.org/2001/XMLSchema#string

M Bochud

http://www.w3.org/2001/XMLSchema#string

M Burnier

http://www.w3.org/2001/XMLSchema#string

M Mohaupt

http://www.w3.org/2001/XMLSchema#string

O Devuyst

http://www.w3.org/2001/XMLSchema#string

P-Y Martin

http://www.w3.org/2001/XMLSchema#string

P2860

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated

11β-Hydroxysteroid dehydrogenase type 1: relevance of its modulation in the pathophysiology of obesity, the metabolic syndrome and type 2 diabetes mellitus.

Copeptin is associated with kidney length, renal function, and prevalence of simple cysts in a population-based study.

Glucocorticoids and type 2 diabetes: from physiology to pathology

Plasma Copeptin, AVP Gene Variants, and Incidence of Type 2 Diabetes in a Cohort From the Community.

Selective inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 for patients with metabolic syndrome: is the target liver, fat, or both?

Plasma copeptin and the risk of diabetes mellitus.

Plasma carboxy-terminal provasopressin (copeptin): a novel marker of insulin resistance and metabolic syndrome.

11β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action.

P2888

s40618-017-0807-7

P304

799-808

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40618-017-0807-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-12-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29235050

http://www.w3.org/2001/XMLSchema#string